Gut check: could your microbiome affect cancer brain fog?
NCT ID NCT06098404
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how gut bacteria might be linked to memory, thinking, and tiredness in people with cancer. Researchers will collect stool samples and do thinking tests at the start and after 6 months of standard cancer treatment. The goal is to find patterns that could help manage these common side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could point toward ways to manage cognitive decline and fatigue in cancer patients by targeting the gut microbiome.
- What could go wrong
- This is a small, early pilot study that only observes and measures—it does not test any treatment. Results may not lead to direct benefits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The University of Texas Medical Branch
RECRUITINGGalveston, Texas, 77555, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A good Night's sleep: could a simple program ease Cancer's toll on rest?
- Could sitting up make radiation therapy more comfortable?
- Can we predict dangerous side effects when combining radiation and immunotherapy?
- Family history as a shield: can culturally tailored guidance cut cancer risk?
- A simple screening program could transform cancer aftercare
- Can simple positive activities boost Well-Being in cancer care?